We have located links that may give you full text access.
Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 2017 Februrary
CONTEXT: Acute kidney injury (AKI) could lead to progressive chronic kidney disease (CKD).
OBJECTIVES: To demonstrate that urinary markers in AKI are associated with the degree of persistent renal injury.
MATERIAL AND METHODS: Human L-FABP chromosomal transgenic (Tg ) mice were subjected to ischemia-reperfusion (I/R) clamping renal pedicle for 20 min or 30 min. Kidneys were obtained at one and 40 days after I/R.
RESULTS: Urinary L-FABP, NGAL, Kim-1 and albumin levels increased during the acute phase and were significantly correlated with the degree of tubulointerstitial fibrosis during the chronic phase.
DISCUSSION AND CONCLUSION: These markers could detect higher risk of progression to CKD.
OBJECTIVES: To demonstrate that urinary markers in AKI are associated with the degree of persistent renal injury.
MATERIAL AND METHODS: Human L-FABP chromosomal transgenic (Tg ) mice were subjected to ischemia-reperfusion (I/R) clamping renal pedicle for 20 min or 30 min. Kidneys were obtained at one and 40 days after I/R.
RESULTS: Urinary L-FABP, NGAL, Kim-1 and albumin levels increased during the acute phase and were significantly correlated with the degree of tubulointerstitial fibrosis during the chronic phase.
DISCUSSION AND CONCLUSION: These markers could detect higher risk of progression to CKD.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app